Episode: 173 - Matt Bettonville on Oncological Research and Drug Discovery Investment

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/6c/10/40/6c10405f-c6b1-abb3-e48f-67492132df13/mza_2647459154515744686.jpg/600x600bb.jpg

Breaking Health

Healthegy

175 episodes

5 days ago

How are innovators driving sustainable ventures to transform Medicaid and improve care for underserved populations? During May’s Digital Healthcare Innovation Summit, Zeena Johar, entrepreneur in residence of Frist Cressey Ventures; Chris Johnson, founder and CEO of Bluebird Kids Health; Aditi Mallick, former CMO of Medicaid and director of Minority Health at CMS; and Jenny Ismert, CEO of Community Plan of Kansas at UnitedHealthcare Community & State gathered to discuss scalable solutions...

All content for Breaking Health is the property of Healthegy and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Technology,

Business

https://storage.buzzsprout.com/uonfelfn916vesqzfbw033fnlg7e?.jpg

Episode: 173 - Matt Bettonville on Oncological Research and Drug Discovery Investment

Breaking Health

27 minutes

5 months ago

Episode: 173 - Matt Bettonville on Oncological Research and Drug Discovery Investment

In this episode of Breaking Health, host Steve Krupa speaks with Matt Bettonville, investor at Yosemite, about the state of oncology research and his hunt for investments in discovery and treatment tools. Bettonville delves into the key to cancer treatment, where deals are flowing towards in the market, and how the AI revolution is helping with drug discovery and cancer treatment breakthroughs. He also discusses the complications (and frustrations) of making treatments affordable, finding new...